Active Surveillance Prostate Cancer Video Chat, January 14th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Phil-Toronto 8:05 PM
Prostate Cancer Journal Club for Patients tomorrow at 9:00am ” can Micro U/S replace MRI for PCa Diagnosis Matt Cooperberg Laurence Klotz meded.ucsf.edu
Martin 8:13 PM
Brian, my email is martinuthe14@gmail.com. I would love to hear about your acqua ablation. Thx!
BJ 8:24 PM
Hi guys anyone have a link for the mentioned webinar tomorrow?
Phil-Toronto 8:25 PM
meded.ucsf.edu. If you google the link it should take you to the registration for the webinar tomorrow
Phil-Toronto 8:36 PM
aquablation vs. HOLEP https://www.perplexity.ai/search/80078b6b-bae2-4382-96d6-4035a1f29ba0
BJ 8:40 PM
Dan P: You mentioned a book at the beginning. if you can put the name of it on the chat. Ty
AnCan – Rick 8:50 PM
Dr. Sanjay Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
BJ 9:01 PM
Need to drop off. Thanks all for sharing so much.
AnCan – Rick 9:06 PM
Helfand webinar on AS on AnCan https://ancan.org/webinar-active-surveillance-beyond-with-dr-brian-helfand/
AnCan – Rick 9:13 PM
@RogerNorris…. PROSTATE, not prostrate.